News & Insights

Community health centers, Head Start agencies, and other recipients of U.S. Department of Health and Human Services (HHS) federal financial assistance should take note of two important upcoming compliance deadlines under new [...]

On March 31, 2026, the U.S. Court of Appeals for the Fourth Circuit, in a 2-1 decision, upheld a preliminary injunction blocking enforcement of West Virginia’s 340B contract pharmacy law. The statute [...]

Feldesman Health Care Compliance Counsel Natalie Lesnick will present “Challenges for Small Covered Entities: How to Build a Robust Privacy/Security Program with Limited Resources” at the 43rd HIPAA Summit, taking place April [...]

Feldesman Partner Steve Kuperberg was recently quoted in the 340B Report in connection with a U.S. Senate investigation into drug pricing practices and their broader impact on safety-net providers. The article examines a [...]

Oregon ruling preserves access to federal funding—for now The U.S. District Court for the District of Oregon has vacated a December 2025 policy issued by the U.S. Department of Health and Human [...]

Recently, a second federal Court of Appeals held that 42 U.S.C. § 233, a provision of the Public Health Service Act relating to Federal Tort Claims Act (FTCA) protection, does not provide [...]

Feldesman Partner Kathy S. Ghiladi will speak at the American Health Law Association’s Medicare and Medicaid Institute, a leading national conference on Medicare and Medicaid policy and compliance, taking place March 18–20, [...]

The Health Resources and Services Administration (HRSA) has published Program Assistance Letter (PAL) 2026-01, Calendar Year 2027 Requirements for Federal Tort Claims Act (FTCA) Coverage for Health Centers and Their Covered Individuals.  [...]

The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies has released its “Fiscal Year 2027 Community Project Funding Guidance.”  The submission deadline for a Member of Congress [...]

Feldesman Partner Steve Kuperberg was recently quoted in the February 26, 2026, edition of the 340B Report on the federal government’s decision to support drug manufacturers in litigation challenging state 340B contract [...]